{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T17:39:57Z","timestamp":1777138797308,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-28169-1","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T12:15:46Z","timestamp":1767010546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of key genes related to glutamine metabolism in diabetic nephropathy by machine learning methods"],"prefix":"10.1038","volume":"15","author":[{"given":"Yuanyuan","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruojing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"28169_CR1","doi-asserted-by":"crossref","unstructured":"Almufleh, A. et al.  Profound vasoplegia during sacubitril\/valsartan treatment after heart transplantation. Can. J. Cardiol.   34(3), 343.e345\u2013343.e347 (2018).","DOI":"10.1016\/j.cjca.2017.12.004"},{"issue":"12","key":"28169_CR2","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1007\/s13300-020-00921-y","volume":"11","author":"A Roy","year":"2020","unstructured":"Roy, A. et al. Kidney disease in type 2 diabetes mellitus and benefits of Sodium-Glucose cotransporter 2 inhibitors: A consensus statement. Diabetes Ther. 11(12), 2791\u20132827 (2020).","journal-title":"Diabetes Ther."},{"issue":"6","key":"28169_CR3","doi-asserted-by":"publisher","first-page":"147916412110588","DOI":"10.1177\/14791641211058856","volume":"18","author":"S Thipsawat","year":"2021","unstructured":"Thipsawat, S. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature. Diab Vasc Dis. Res. 18(6), 14791641211058856 (2021).","journal-title":"Diab Vasc Dis. Res."},{"issue":"42","key":"28169_CR4","doi-asserted-by":"publisher","first-page":"e31232","DOI":"10.1097\/MD.0000000000031232","volume":"101","author":"S Li","year":"2022","unstructured":"Li, S., Xie, H., Shi, Y. & Liu, H. Prevalence of diabetic nephropathy in the diabetes mellitus population: A protocol for systematic review and meta-analysis. Med. (Baltim). 101(42), e31232 (2022).","journal-title":"Med. (Baltim)."},{"issue":"6","key":"28169_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11892-021-01387-3","volume":"21","author":"YK Lin","year":"2021","unstructured":"Lin, Y. K. et al. The prevalence of diabetic microvascular complications in China and the USA. Curr. Diab Rep. 21(6), 16 (2021).","journal-title":"Curr. Diab Rep."},{"key":"28169_CR6","doi-asserted-by":"publisher","first-page":"8637138","DOI":"10.1155\/2017\/8637138","volume":"2017","author":"C Qi","year":"2017","unstructured":"Qi, C., Mao, X., Zhang, Z. & Wu, H. Classification and differential diagnosis of diabetic nephropathy. J. Diabetes Res. 2017, 8637138 (2017).","journal-title":"J. Diabetes Res."},{"key":"28169_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000324942","volume":"170","author":"B Najafian","year":"2011","unstructured":"Najafian, B., Alpers, C. E. & Fogo, A. B. Pathology of human diabetic nephropathy. Contrib. Nephrol. 170, 36\u201347 (2011).","journal-title":"Contrib. Nephrol."},{"issue":"7","key":"28169_CR8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/14728222.2019.1624721","volume":"23","author":"AM Warren","year":"2019","unstructured":"Warren, A. M., Knudsen, S. T. & Cooper, M. E. Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies. Expert Opin. Ther. Targets. 23(7), 579\u2013591 (2019).","journal-title":"Expert Opin. Ther. Targets"},{"key":"28169_CR9","doi-asserted-by":"publisher","first-page":"1127612","DOI":"10.3389\/fimmu.2023.1127612","volume":"14","author":"X Li","year":"2023","unstructured":"Li, X. et al. GBP2 promotes M1 macrophage polarization by activating the notch1 signaling pathway in diabetic nephropathy. Front. Immunol. 14, 1127612 (2023).","journal-title":"Front. Immunol."},{"key":"28169_CR10","doi-asserted-by":"publisher","first-page":"1113212","DOI":"10.3389\/fimmu.2023.1113212","volume":"14","author":"H Zhou","year":"2023","unstructured":"Zhou, H., Mu, L., Yang, Z. & Shi, Y. Identification of a novel immune landscape signature as effective diagnostic markers related to immune cell infiltration in diabetic nephropathy. Front. Immunol. 14, 1113212 (2023).","journal-title":"Front. Immunol."},{"key":"28169_CR11","doi-asserted-by":"crossref","unstructured":"Md Dom, Z. I. et al. Circulating proteins protect against renal decline and progression to end-stage renal disease in patients with diabetes. Sci. Transl. Med. 13(600)  (2021).","DOI":"10.1126\/scitranslmed.abd2699"},{"key":"28169_CR12","doi-asserted-by":"crossref","unstructured":"Liu, L. et al. Metabolic homeostasis of amino acids and diabetic kidney disease. Nutrients 15(1)  (2022).","DOI":"10.3390\/nu15010184"},{"issue":"4","key":"28169_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nm.4514","volume":"24","author":"RA Miller","year":"2018","unstructured":"Miller, R. A. et al. Targeting hepatic glutaminase activity to ameliorate hyperglycemia. Nat. Med. 24(4), 518\u2013524 (2018).","journal-title":"Nat. Med."},{"issue":"2","key":"28169_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/13813455.2020.1828478","volume":"129","author":"M Nasri","year":"2023","unstructured":"Nasri, M., Adibhesami, G., Mahdavifard, S., Babaeenezhad, E. & Ahmadvand, H. Exogenous glutamine ameliorates diabetic nephropathy in a rat model of type 2 diabetes mellitus through its antioxidant and anti-inflammatory activities. Arch. Physiol. Biochem. 129(2), 363\u2013372 (2023).","journal-title":"Arch. Physiol. Biochem."},{"issue":"9","key":"28169_CR15","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1080\/0886022X.2016.1227918","volume":"38","author":"S Sadar","year":"2016","unstructured":"Sadar, S., Kaspate, D. & Vyawahare, N. Protective effect of L-glutamine against diabetes-induced nephropathy in experimental animal: role of KIM-1, NGAL, TGF-\u03b21, and collagen-1. Ren. Fail. 38(9), 1483\u20131495 (2016).","journal-title":"Ren. Fail."},{"issue":"11","key":"28169_CR16","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/mc.23100","volume":"58","author":"K Chen","year":"2019","unstructured":"Chen, K. et al. Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma-specific survival. Mol. Carcinog. 58(11), 2091\u20132103 (2019).","journal-title":"Mol. Carcinog."},{"key":"28169_CR17","doi-asserted-by":"publisher","first-page":"864407","DOI":"10.3389\/fendo.2022.864407","volume":"13","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. Screening of the key genes and signalling pathways for diabetic nephropathy using bioinformatics analysis. Front. Endocrinol. (Lausanne). 13, 864407 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"28169_CR18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2105-14-244","volume":"14","author":"H Zhang","year":"2013","unstructured":"Zhang, H., Meltzer, P. & Davis, S. RCircos: an R package for circos 2D track plots. BMC Bioinform. 14, 244 (2013).","journal-title":"BMC Bioinform."},{"key":"28169_CR19","doi-asserted-by":"crossref","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53(D1), D672\u2013D677 (2025).","DOI":"10.1093\/nar\/gkae909"},{"key":"28169_CR20","doi-asserted-by":"publisher","first-page":"1026938","DOI":"10.3389\/fendo.2022.1026938","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang, H., Hu, J., Zhu, J., Li, Q. & Fang, L. Machine learning-based metabolism-related genes signature and immune infiltration landscape in diabetic nephropathy. Front. Endocrinol. (Lausanne). 13, 1026938 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"28169_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33(1), 1\u201322 (2010).","journal-title":"J. Stat. Softw."},{"issue":"1","key":"28169_CR22","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12859-018-2451-4","volume":"19","author":"H Sanz","year":"2018","unstructured":"Sanz, H., Valim, C., Vegas, E., Oller, J. M. & Reverter, F. SVM-RFE: selection and visualization of the most relevant features through non-linear kernels. BMC Bioinform. 19(1), 432 (2018).","journal-title":"BMC Bioinform."},{"key":"28169_CR23","doi-asserted-by":"crossref","unstructured":"Yan, B., Ren, F., Shang, W. & Gong, X. Transcriptomic Analysis Reveals Genetic Cross-Talk between Periodontitis and Hypothyroidism. Dis. Markers 2022, 5736394 (2022).","DOI":"10.1155\/2022\/5736394"},{"key":"28169_CR24","doi-asserted-by":"publisher","first-page":"105523","DOI":"10.1016\/j.dib.2020.105523","volume":"30","author":"T Li","year":"2020","unstructured":"Li, T. et al. Data analysis of PD-1 antibody in the treatment of melanoma patients. Data Brief. 30, 105523 (2020).","journal-title":"Data Brief."},{"key":"28169_CR25","doi-asserted-by":"publisher","first-page":"916934","DOI":"10.3389\/fimmu.2022.916934","volume":"13","author":"J Qing","year":"2022","unstructured":"Qing, J. et al. Differentiation of T helper 17 cells May mediate the abnormal humoral immunity in IgA nephropathy and inflammatory bowel disease based on shared genetic effects. Front. Immunol. 13, 916934 (2022).","journal-title":"Front. Immunol."},{"key":"28169_CR26","doi-asserted-by":"publisher","first-page":"732822","DOI":"10.3389\/fgene.2021.732822","volume":"12","author":"K Zhao","year":"2021","unstructured":"Zhao, K., Ma, Z. & Zhang, W. Comprehensive analysis to identify SPP1 as a prognostic biomarker in cervical cancer. Front. Genet. 12, 732822 (2021).","journal-title":"Front. Genet."},{"key":"28169_CR27","doi-asserted-by":"publisher","first-page":"1201297","DOI":"10.3389\/fonc.2023.1201297","volume":"13","author":"H Li","year":"2023","unstructured":"Li, H., Wu, Z., Zhang, Y., Lu, X. & Miao, L. Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival. Front. Oncol. 13, 1201297 (2023).","journal-title":"Front. Oncol."},{"key":"28169_CR28","doi-asserted-by":"publisher","first-page":"1196372","DOI":"10.3389\/fendo.2023.1196372","volume":"14","author":"P Zhang","year":"2023","unstructured":"Zhang, P. et al. Integrating multiple machine learning methods to construct glutamine metabolism-related signatures in lung adenocarcinoma. Front. Endocrinol. (Lausanne). 14, 1196372 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"28169_CR29","doi-asserted-by":"crossref","unstructured":"Wang, H. et al. A Five glutamine-associated signature predicts prognosis of prostate cancer and links glutamine metabolism with tumor microenvironment. J. Clin. Med. 12(6)  (2023).","DOI":"10.3390\/jcm12062243"},{"key":"28169_CR30","doi-asserted-by":"publisher","first-page":"1135297","DOI":"10.3389\/fendo.2023.1135297","volume":"14","author":"S Pei","year":"2023","unstructured":"Pei, S. et al. Integrating single-cell RNA-seq and bulk RNA-seq to construct prognostic signatures to explore the role of glutamine metabolism in breast cancer. Front. Endocrinol. (Lausanne). 14, 1135297 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"28169_CR31","doi-asserted-by":"publisher","first-page":"6895","DOI":"10.1038\/s41598-023-33277-x","volume":"13","author":"Z Wu","year":"2023","unstructured":"Wu, Z. et al. A novel alzheimer\u2019s disease prognostic signature: identification and analysis of glutamine metabolism genes in immunogenicity and immunotherapy efficacy. Sci. Rep. 13(1), 6895 (2023).","journal-title":"Sci. Rep."},{"issue":"2","key":"28169_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/brainsci13020175","volume":"20","author":"Y Bao","year":"2023","unstructured":"Bao, Y., Wang, L., Yu, F., Yang, J. & Huang, D. Parkinson\u2019s disease gene biomarkers screened by the LASSO and SVM algorithms. Brain Sci. 20(2), 175 (2023).","journal-title":"Brain Sci."},{"key":"28169_CR33","doi-asserted-by":"crossref","unstructured":"Scalise, M. et al. Chemical approaches for studying the biology and pharmacology of membrane transporters: the histidine\/large amino acid transporter SLC7A5 as a benchmark. Molecules 26(21)  (2021).","DOI":"10.3390\/molecules26216562"},{"issue":"2","key":"28169_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0005-2736(01)00384-4","volume":"1514","author":"O Yanagida","year":"2001","unstructured":"Yanagida, O. et al. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim. Biophys. Acta. 1514(2), 291\u2013302 (2001).","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"28169_CR35","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.semcancer.2005.04.005","volume":"15","author":"BC Fuchs","year":"2005","unstructured":"Fuchs, B. C. & Bode, B. P. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin Cancer Biol. 15(4), 254\u2013266 (2005).","journal-title":"Semin Cancer Biol."},{"issue":"2","key":"28169_CR36","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1042\/BST20180250","volume":"47","author":"K Javed","year":"2019","unstructured":"Javed, K. & Fairweather, S. J. Amino acid transporters in the regulation of insulin secretion and signalling. Biochem. Soc. Trans. 47(2), 571\u2013590 (2019).","journal-title":"Biochem. Soc. Trans."},{"key":"28169_CR37","doi-asserted-by":"crossref","unstructured":"Kahlhofer, J. & Teis, D. The human LAT1-4F2hc (SLC7A5-SLC3A2) transporter complex: physiological and pathophysiological implications. Basic Clin. Pharmacol. Toxicol(2022).","DOI":"10.1111\/bcpt.13821"},{"issue":"13","key":"28169_CR38","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1167\/iovs.18-25497","volume":"59","author":"M Yuzawa","year":"2018","unstructured":"Yuzawa, M. et al. Genome-Wide association study to identify a new susceptibility locus for central serous chorioretinopathy in the Japanese population. Invest. Ophthalmol. Vis. Sci. 59(13), 5542\u20135547 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"28169_CR39","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.bbabio.2016.04.003","volume":"1857","author":"CB Rueda","year":"2016","unstructured":"Rueda, C. B. et al. Glutamate excitotoxicity and Ca2+-regulation of respiration: role of the Ca2\u2009+\u2009activated mitochondrial transporters (CaMCs). Biochim. Biophys. Acta. 1857(8), 1158\u20131166 (2016).","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"28169_CR40","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s12035-015-9116-3","volume":"53","author":"Y Aoki","year":"2016","unstructured":"Aoki, Y. & Cortese, S. Mitochondrial Aspartate\/Glutamate carrier SLC25A12 and autism spectrum disorder: a Meta-Analysis. Mol. Neurobiol. 53(3), 1579\u20131588 (2016).","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"28169_CR41","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41398-022-02009-6","volume":"12","author":"S Qiu","year":"2022","unstructured":"Qiu, S., Qiu, Y., Li, Y. & Cong, X. Genetics of autism spectrum disorder: an umbrella review of systematic reviews and meta-analyses. Transl Psychiatry. 12(1), 249 (2022).","journal-title":"Transl Psychiatry"},{"issue":"7","key":"28169_CR42","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3923\/pjbs.2020.973.976","volume":"23","author":"M Saleh","year":"2020","unstructured":"Saleh, M., Helmi, M. & Yacop, B. A novel nonsense gene variant responsible for early infantile epileptic encephalopathy type 39: case report. Pak J. Biol. Sci. 23(7), 973\u2013976 (2020).","journal-title":"Pak J. Biol. Sci."},{"issue":"3","key":"28169_CR43","doi-asserted-by":"publisher","first-page":"e51436","DOI":"10.15252\/embr.202051436","volume":"3","author":"G Pathria","year":"2021","unstructured":"Pathria, G., Verma, S., Yin, J., Scott, D. A. & Ronai, Z. A. MAPK signaling regulates c-MYC for melanoma cell adaptation to asparagine restriction. EMBO Rep. 3(3), e51436 (2021).","journal-title":"EMBO Rep."},{"key":"28169_CR44","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.2147\/DDDT.S319260","volume":"15","author":"L Ma","year":"2021","unstructured":"Ma, L. et al. Baicalin alleviates oxidative stress and inflammation in diabetic nephropathy via Nrf2 and MAPK signaling pathway. Drug Des. Devel Ther. 15, 3207\u20133221 (2021).","journal-title":"Drug Des. Devel Ther."},{"key":"28169_CR45","doi-asserted-by":"crossref","unstructured":"Wu, T., Ding, L., Andoh, V., Zhang, J. & Chen, L. The mechanism of Hyperglycemia-Induced renal cell injury in diabetic nephropathy disease: an update. Life (Basel) 13(2)  (2023).","DOI":"10.3390\/life13020539"},{"issue":"2","key":"28169_CR46","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1074\/jbc.RA119.010511","volume":"295","author":"K Yasukawa","year":"2020","unstructured":"Yasukawa, K., Kinoshita, D., Yaku, K., Nakagawa, T. & Koshiba, T. The MicroRNAs miR-302b and miR-372 regulate mitochondrial metabolism via the SLC25A12 transporter, which controls MAVS-mediated antiviral innate immunity. J. Biol. Chem. 295(2), 444\u2013457 (2020).","journal-title":"J. Biol. Chem."},{"issue":"5","key":"28169_CR47","first-page":"7356","volume":"17","author":"DD Yin","year":"2018","unstructured":"Yin, D. D., Luo, J. H., Zhao, Z. Y., Liao, Y. J. & Li, Y. Tranilast prevents renal interstitial fibrosis by blocking mast cell infiltration in a rat model of diabetic kidney disease. Mol. Med. Rep. 17(5), 7356\u20137364 (2018).","journal-title":"Mol. Med. Rep."},{"key":"28169_CR48","doi-asserted-by":"crossref","unstructured":"Pandey, A. et al. Current Insights into miRNA and lncRNA dysregulation in diabetes: Signal transduction, clinical trials and biomarker discovery. Pharmaceuticals (Basel) 15(10)  (2022).","DOI":"10.3390\/ph15101269"},{"issue":"4","key":"28169_CR49","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2174\/1389202923666220531105035","volume":"23","author":"Z Song","year":"2022","unstructured":"Song, Z., He, C., Wen, J., Yang, J. & Chen, P. Long Non-coding rnas: pivotal epigenetic regulators in diabetic retinopathy. Curr. Genomics. 23(4), 246\u2013261 (2022).","journal-title":"Curr. Genomics"},{"key":"28169_CR50","doi-asserted-by":"publisher","first-page":"1124613","DOI":"10.3389\/fendo.2023.1124613","volume":"14","author":"MT Macvanin","year":"2023","unstructured":"Macvanin, M. T. et al. Diabetic cardiomyopathy: the role of MicroRNAs and long non-coding RNAs. Front. Endocrinol. (Lausanne). 14, 1124613 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"28169_CR51","doi-asserted-by":"publisher","first-page":"20230710","DOI":"10.1515\/med-2023-0710","volume":"18","author":"H Li","year":"2023","unstructured":"Li, H., Hao, J. & Yu, W. LncRNA CASC15 Inhibition relieves renal fibrosis in diabetic nephropathy through down-regulating SP-A by sponging to miR-424. Open. Med. (Wars). 18(1), 20230710 (2023).","journal-title":"Open. Med. (Wars)"},{"issue":"2","key":"28169_CR52","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41419-023-05695-2","volume":"14","author":"J Guo","year":"2023","unstructured":"Guo, J. et al. Long non-coding RNA DLX6-AS1 is the key mediator of glomerular podocyte injury and albuminuria in diabetic nephropathy by targeting the miR-346\/GSK-3\u03b2 signaling pathway. Cell. Death Dis. 14(2), 172 (2023).","journal-title":"Cell. Death Dis."},{"issue":"4","key":"28169_CR53","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1007\/s11033-023-08254-2","volume":"50","author":"BW Xu","year":"2023","unstructured":"Xu, B. W., Rao, Y., Wang, L., Chen, S. M. & Zou, S. B. LncRNA MEG3 inhibits renal fibrinoid necrosis of diabetic nephropathy via the MEG3\/miR-21\/ORAI1 axis. Mol. Biol. Rep. 50(4), 3283\u20133295 (2023).","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"28169_CR54","doi-asserted-by":"publisher","first-page":"20278","DOI":"10.1038\/s41598-022-24851-w","volume":"12","author":"MT Coughlan","year":"2022","unstructured":"Coughlan, M. T., Ziemann, M., Laskowski, A., Woodruff, T. M. & Tan, S. M. Valproic acid attenuates cellular senescence in diabetic kidney disease through the Inhibition of complement C5a receptors. Sci. Rep. 12(1), 20278 (2022).","journal-title":"Sci. Rep."},{"key":"28169_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2014.12.015","volume":"110","author":"S Khan","year":"2015","unstructured":"Khan, S., Jena, G., Tikoo, K. & Kumar, V. Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-\u03baB\/iNOS signaling in diabetic rat. Biochimie 110, 1\u201316 (2015).","journal-title":"Biochimie"},{"issue":"2","key":"28169_CR56","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.yexmp.2015.01.003","volume":"98","author":"S Khan","year":"2015","unstructured":"Khan, S., Jena, G. & Tikoo, K. Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the Inhibition of histone deacetylases in diabetic rat. Exp. Mol. Pathol. 98(2), 230\u2013239 (2015).","journal-title":"Exp. Mol. Pathol."},{"issue":"5","key":"28169_CR57","first-page":"4041","volume":"22","author":"X Sun","year":"2020","unstructured":"Sun, X., Sun, Y., Lin, S., Xu, Y. & Zhao, D. Histone deacetylase inhibitor valproic acid attenuates high glucose\u2013induced Endoplasmic reticulum stress and apoptosis in NRK\u201352E cells. Mol. Med. Rep. 22(5), 4041\u20134047 (2020).","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"28169_CR58","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3892\/mmr.2015.4580","volume":"13","author":"XY Sun","year":"2016","unstructured":"Sun, X. Y. et al. Valproate attenuates diabetic nephropathy through Inhibition of Endoplasmic reticulum stress\u2013induced apoptosis. Mol. Med. Rep. 13(1), 661\u2013668 (2016).","journal-title":"Mol. Med. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28169-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28169-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28169-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T17:03:23Z","timestamp":1777136603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28169-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28169"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28169-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving human participants were reviewed and approved by The First Affiliated Hospital of Zhengzhou University and was performed according to the guidance and principles of the World Medical Association\u2019s Declaration of Helsinki. The patients\/participants provided their written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"45703"}}